Continuous infusional combination chemotherapy in inflammatory breast cancer: a phase II study
- 30 June 2000
- journal article
- Published by Elsevier in The Breast
- Vol. 9 (3) , 149-155
- https://doi.org/10.1054/brst.1999.0158
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Outcomes of High-Dose Chemotherapy and Autologous Stem-Cell Transplantation in Stage IIIB Inflammatory Breast CancerJournal of Clinical Oncology, 1999
- High-dose chemotherapy with autologous hematopoietic progenitor-cell support as part of combined modality therapy in patients with inflammatory breast cancer.Journal of Clinical Oncology, 1998
- High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer: pathologic response and outcomeBone Marrow Transplantation, 1998
- Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimenBritish Journal of Cancer, 1996
- Prognostic factors in inflammatory breast cancer and therapeutic implicationsEuropean Journal Of Cancer, 1994
- Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: Univariate and multivariate analysisEuropean Journal Of Cancer, 1993
- Inflammatory breast cancer: a review.Journal of Clinical Oncology, 1992
- Management of inflammatory carcinoma of the breastAmerican Journal of Clinical Oncology, 1985
- Inflammatory Breast CancerSurgical Clinics of North America, 1985
- Inflammatory carcinoma of the breastCancer, 1978